These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Factors affecting the metabolism of benzodiazepines and related clinical significances]. Zhang Y; Long CF; Lou YQ Zhonghua Nei Ke Za Zhi; 1994 Dec; 33(12):844-7. PubMed ID: 7768143 [No Abstract] [Full Text] [Related]
43. Implications of altered drug disposition in the elderly: studies of benzodiazepines. Greenblatt DJ; Shader RI; Harmatz JS J Clin Pharmacol; 1989 Oct; 29(10):866-72. PubMed ID: 2574189 [No Abstract] [Full Text] [Related]
46. [Use of preparations of the benzodiazepine group in the treatment of epilepsy (review of the literature)]. Levinskiĭ MV Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(6):118-26. PubMed ID: 2571215 [No Abstract] [Full Text] [Related]
47. [Clinical and pharmacokinetic aspects of the problem of benzodiazepine derivatives (review of foreign literature)]. Go'rkov VA; Tarasova TP; Gertsik LG Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(5):132-41. PubMed ID: 2571214 [No Abstract] [Full Text] [Related]
48. [Pharmacotherapy with benzodiazepines: basic principles and new developments]. Möhler H Praxis (Bern 1994); 1998 Feb; 87(6):186-90. PubMed ID: 9531812 [TBL] [Abstract][Full Text] [Related]
49. [Pharmacology and clinical aspects of benzodiazepines]. Mendlewicz J; Sevy S Encephale; 1985; 11(6):255-9. PubMed ID: 2869938 [TBL] [Abstract][Full Text] [Related]
51. [Current status of treatment with benzodiazepines]. Laux G Nervenarzt; 1995 May; 66(5):311-22. PubMed ID: 7609811 [TBL] [Abstract][Full Text] [Related]